Skip to main content
Log in

Anything new in EU pharmacovigilance?

  • Point of View
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Regulation (EU) No 1235/2010 of the European Parliament and of the Council of 15 December 2010 amending, as regards pharmacovigilance of medicinal products for human use, Regulation (EC) No 726/2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency, and Regulation (EC) No 1394/2007 on advanced therapy medicinal products. Available at: http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2010:348:0001:0016:EN:PDF

  2. Directive 2010/84/EU of the European Parliament and of the Council of 15 December 2010 amending, as regards pharmacovigilance, Directive 2001/83/EC on the Community code relating to medicinal products for human use. Available at: http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2010:348:0074:0099:EN:PDF

  3. Frau S, Font Pous M, Luppino MR, Conforti A (2010) Risk management plans: are they a tool for improving drug safety? Eur J Clin Pharmacol 66:785–790. doi:10.1007/s00228-010-0848-8

    Article  PubMed  CAS  Google Scholar 

  4. Garattini S, Bertele' V (2010) Rosiglitazone and the need for a new drug safety agency. Br Med J 341:c5506. doi:10.1136/bmj.c5506

    Article  Google Scholar 

Download references

Acknowledgements

We thank Judith Baggott for editing.

Conflict of interests

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Vittorio Bertele’.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Garattini, S., Bertele’, V. Anything new in EU pharmacovigilance?. Eur J Clin Pharmacol 67, 1199–1200 (2011). https://doi.org/10.1007/s00228-011-1052-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-011-1052-1

Keywords

Navigation